Advances in the structural studies of antibiotic potentiators against Escherichia coli

Bioorganic & Medicinal Chemistry
2019.0

Abstract

Studies from our laboratory have indicated that amides derived from 3-amino-1,5-diphenylpentane can potentiate the antibiotic activity of clarithromycin against Escherichia coli. In the present study, the impact on activity of reversing the amide moiety within this series of compounds was investigated, and desoxy derivatives of three of the reversed amide derivatives were also synthesized and evaluated. In general, the reversed amides exhibited enhanced potency as potentiators of antibiotic activity against E. coli. Compound 7 (the N1-1,2,5-triaminopentyl amide of 3,3-dibenzylpropanoic acid) proved to be the most active analog, lowering the MIC of clarithromycin by 512-fold and having 128-fold greater potency than PAβN. The desoxy derivatives 22 and 23 were 8-fold and 4-fold more potent than their carboxamides (4 and 11) respectively. Compounds 7 and 22 were effective at potentiating the activity of not only clarithromycin, but also of other antibiotics, including minocycline, novobiocin, clindamycin, and azithromycin. The collective results of cell-based studies suggest that the antibiotic potentiating activities of 7 and 22 reflect contributions from both membrane permeabilization and efflux pump inhibition, but not from disruption of the proton gradient or potential across the membrane.

Knowledge Graph

Similar Paper

Advances in the structural studies of antibiotic potentiators against Escherichia coli
Bioorganic & Medicinal Chemistry 2019.0
Structure-activity relationships of potentiators of the antibiotic activity of clarithromycin against Escherichia coli
European Journal of Medicinal Chemistry 2019.0
Augmenting the Activity of Macrolide Adjuvants against Acinetobacter baumannii
ACS Medicinal Chemistry Letters 2020.0
Synthesis and antibacterial activity of novel 3-O-arylalkylcarbamoyl-3-O-descladinosyl-9-O-(2-chlorobenzyl)oxime clarithromycin derivatives
Bioorganic & Medicinal Chemistry Letters 2018.0
Synthesis and antibacterial activity of novel 3-O-carbamoyl derivatives of clarithromycin and 11,12-cyclic carbonate azithromycin
European Journal of Medicinal Chemistry 2010.0
A novel series of 11-O-carbamoyl-3-O-descladinosyl clarithromycin derivatives bearing 1,2,3-triazole group: Design, synthesis and antibacterial evaluation
Bioorganic & Medicinal Chemistry Letters 2020.0
Design, synthesis and antibacterial evaluation of novel C-11, C-9 or C-2′-substituted 3-O-descladinosyl-3-ketoclarithromycin derivatives
Bioorganic & Medicinal Chemistry Letters 2021.0
Synthesis and antibacterial activities of a novel alkylide: 3-O-(3-aryl-2-propargyl) and 3-O-(3-aryl-2-propenyl)clarithromycin derivatives
Bioorganic & Medicinal Chemistry Letters 2010.0
New Ianthelliformisamine Derivatives as Antibiotic Enhancers against Resistant Gram-Negative Bacteria
Journal of Medicinal Chemistry 2014.0
Synthesis and antibacterial activity of novel 4″-O-arylalkylcarbamoyl and 4″-O-((arylalkylamino)-4-oxo-butyl)carbamoyl clarithromycin derivatives
Bioorganic & Medicinal Chemistry Letters 2010.0